Literature DB >> 22820289

PES1 promotes breast cancer by differentially regulating ERα and ERβ.

Long Cheng1, Jieping Li, Yongjian Han, Jing Lin, Chang Niu, Zhichao Zhou, Bin Yuan, Ke Huang, Jiezhi Li, Kai Jiang, Hao Zhang, Lihua Ding, Xiaojie Xu, Qinong Ye.   

Abstract

The initiation of breast cancer is associated with increased expression of tumor-promoting estrogen receptor α (ERα) protein and decreased expression of tumor-suppressive ERβ protein. However, the mechanism underlying this process is unknown. Here we show that PES1 (also known as Pescadillo), an estrogen-inducible protein that is overexpressed in breast cancer, can regulate the balance between ERα and ERβ. We found that PES1 modulated many estrogen-responsive genes by enhancing the transcriptional activity of ERα while inhibiting transcriptional activity of ERβ. Consistent with this regulation of ERα and ERβ transcriptional activity, PES1 increased the stability of the ERα protein and decreased that of ERβ through the ubiquitin-proteasome pathway, mediated by the carboxyl terminus of Hsc70-interacting protein (CHIP). Moreover, PES1 transformed normal human mammary epithelial cells and was required for estrogen-induced breast tumor growth in nude mice. Further analysis of clinical samples showed that expression of PES1 correlated positively with ERα expression and negatively with ERβ expression and predicted good clinical outcome in breast cancer. Our data demonstrate that PES1 contributes to breast tumor growth through regulating the balance between ERα and ERβ and may be a better target for the development of drugs that selectively regulate ERα and ERβ activities.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820289      PMCID: PMC3408741          DOI: 10.1172/JCI62676

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

Review 1.  Estrogens and cell-cycle regulation in breast cancer.

Authors:  J S Foster; D C Henley; S Ahamed; J Wimalasena
Journal:  Trends Endocrinol Metab       Date:  2001-09       Impact factor: 12.015

Review 2.  Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

Authors:  B Lawrence Riggs; Lynn C Hartmann
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

3.  Putative functional characteristics of human estrogen receptor-beta isoforms.

Authors:  B Peng; B Lu; E Leygue; L C Murphy
Journal:  J Mol Endocrinol       Date:  2003-02       Impact factor: 5.098

4.  Effects of estrogen on global gene expression: identification of novel targets of estrogen action.

Authors:  A H Charpentier; A K Bednarek; R L Daniel; K A Hawkins; K J Laflin; S Gaddis; M C MacLeod; C M Aldaz
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

5.  Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.

Authors:  P Roger; M E Sahla; S Mäkelä; J A Gustafsson; P Baldet; H Rochefort
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

6.  Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice.

Authors:  Marie K Lindberg; Sofia Movérare; Stanko Skrtic; Hui Gao; Karin Dahlman-Wright; Jan-Ake Gustafsson; Claes Ohlsson
Journal:  Mol Endocrinol       Date:  2003-02

Review 7.  ERbeta in breast cancer--onlooker, passive player, or active protector?

Authors:  Emily M Fox; Rebecca J Davis; Margaret A Shupnik
Journal:  Steroids       Date:  2008-04-20       Impact factor: 2.668

8.  Ligand-independent activation of estrogen receptor alpha by XBP-1.

Authors:  Lihua Ding; Jinghua Yan; Jianhua Zhu; Hongjun Zhong; Qiujun Lu; Zonghua Wang; Cuifen Huang; Qinong Ye
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

9.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.

Authors:  Jonna Frasor; Jeanne M Danes; Barry Komm; Ken C N Chang; C Richard Lyttle; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2003-07-10       Impact factor: 4.736

10.  Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7.

Authors:  Yoko Omoto; Hidetaka Eguchi; Yuri Yamamoto-Yamaguchi; Shin-ichi Hayashi
Journal:  Oncogene       Date:  2003-08-07       Impact factor: 9.867

View more
  34 in total

1.  Significance of estrogen receptor subtypes in breast tumorigenesis and progression.

Authors:  Weiliang Sun; Chijiang Gu; Minming Xia; Guoping Zhong; Haojun Song; Junming Guo
Journal:  Tumour Biol       Date:  2014-06-11

2.  The molecular mechanism and potential role of heat shock-induced p53 protein accumulation.

Authors:  Juqiang Han; Xiaojie Xu; Hongzhen Qin; Anheng Liu; Zhongyi Fan; Lei Kang; Jing Fu; Jiahong Liu; Qinong Ye
Journal:  Mol Cell Biochem       Date:  2013-03-02       Impact factor: 3.396

3.  Targeting PES1 for restoring the ERα/ERβ ratio in breast cancer.

Authors:  Christoforos Thomas; Jan-Åke Gustafsson
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

4.  Repression of PES1 expression inhibits growth of gastric cancer.

Authors:  Jieping Li; Xiaodong Zhou; Xiaopeng Lan; Guobin Zeng; Xuping Jiang; Zongming Huang
Journal:  Tumour Biol       Date:  2015-09-30

5.  Is breast cancer a result of epigenetic responses to traffic-related air pollution? A review of the latest evidence.

Authors:  Debashish Sahay; Mary B Terry; Rachel Miller
Journal:  Epigenomics       Date:  2019-05-09       Impact factor: 4.778

6.  Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.

Authors:  Xiaojie Xu; Zhongyi Fan; Lei Kang; Juqiang Han; Chengying Jiang; Xiaofei Zheng; Ziman Zhu; Huabo Jiao; Jing Lin; Kai Jiang; Lihua Ding; Hao Zhang; Long Cheng; Hanjiang Fu; Yi Song; Ying Jiang; Jiahong Liu; Rongfu Wang; Nan Du; Qinong Ye
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

7.  A phosphotyrosine switch determines the antitumor activity of ERβ.

Authors:  Bin Yuan; Long Cheng; Huai-Chin Chiang; Xiaojie Xu; Yongjian Han; Hang Su; Lingxue Wang; Bo Zhang; Jing Lin; Xiaobing Li; Xiangyang Xie; Tao Wang; Rajeshwar R Tekmal; Tyler J Curiel; Zhi-Min Yuan; Richard Elledge; Yanfen Hu; Qinong Ye; Rong Li
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

8.  Mediator of ERBB2-driven cell motility (MEMO) promotes extranuclear estrogen receptor signaling involving the growth factor receptors IGF1R and ERBB2.

Authors:  Kai Jiang; Zhihong Yang; Long Cheng; Shibin Wang; Kang Ning; Lei Zhou; Jing Lin; Hui Zhong; Lisheng Wang; Yang Li; Junjian Huang; Hao Zhang; Qinong Ye
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

9.  The Crystal Structure of the Ubiquitin-like Domain of Ribosome Assembly Factor Ytm1 and Characterization of Its Interaction with the AAA-ATPase Midasin.

Authors:  Erin M Romes; Mack Sobhany; Robin E Stanley
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

10.  Reciprocal Regulation of ERα and ERβ Stability and Activity by Diptoindonesin G.

Authors:  Zibo Zhao; Lu Wang; Taryn James; Youngeun Jung; Ikyon Kim; Renxiang Tan; F Michael Hoffmann; Wei Xu
Journal:  Chem Biol       Date:  2015-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.